Form 4: Biodesix Director Jack W. Schuler Acquires Additional Shares

Director Jack W. Schuler reports purchasing additional Biodesix shares through multiple transactions, increasing his indirect holdings.

Summary

• Jack W. Schuler, a director and 10% owner of Biodesix Inc., has reported changes in his beneficial ownership of the company's common stock.
• On May 16, 2025, Schuler purchased 4,000,000 shares at a weighted average price of $0.2675, with individual prices ranging from $0.2215 to $0.3397.
• On May 19, 2025, he purchased an additional 723,239 shares at a weighted average price of $0.341, with individual prices ranging from $0.2997 to $0.36.
• These purchases were made indirectly through the Jack W. Schuler Living Trust.
• Schuler also reported a transfer of 15,000,000 shares from the Jack W. Schuler Living Trust to the Jack W. Schuler 2025 GRAT on January 29, 2025.
• Following these transactions, Schuler's indirect holdings through the Living Trust amount to 20,918,174 shares, and he indirectly holds 15,000,000 shares through the 2025 GRAT.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's purchase of shares suggests confidence, but it's a routine transaction.

Positives

• The director's purchase of additional shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal.

Key Dates

Keywords

Biodesix, BDSX, Jack W. Schuler, Beneficial Ownership, Share Purchase, Director, Form 4, Living Trust, Grat